Finally, regarding the clinical outcomes evaluated in the studies, AKI (Khaled et al., 2016; Seligson et al., 2024; Zhu et al., 2020), TMA (Khaled et al., 2016) or OS, RFS and NRM (Ho et al., 2024) were not influenced by ABCB1 polymorphisms. The gene discussed is ABCB1; the disease is acute kidney injury.